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Abstract
The present study tested the hypothesis that spontaneously hypertensive rats
(SHR) have impaired nitric oxide synthase (NOS)-mediated regulation of vascular function versus Wistar-Kyoto rats (WKY). Aorta and small mesenteric
arteries were studied from male and female SHR (M SHR and F SHR) and
WKY (M WKY and F WKY). Phenylephrine (PE)-induced vasoconstriction was
greater in aorta of M SHR versus all others (P < 0.05); there were neither sex
nor strain differences in PE contraction in mesenteric arteries. The NOS inhibitor L-Nitro-Arginine Methyl Ester (L-NAME) increased PE-induced vasoconstriction in all rats, although the increase was the least in male SHR (P < 0.05),
revealing a blunted vasoconstrictor buffering capacity of NOS. L-NAME
increased sensitivity to PE-induced constriction only in mesenteric arteries of
SHR, although, the maximal percent increase in contraction was comparable
among groups. ACh-induced relaxation was also less in aorta from M SHR versus all others (P < 0.05). ACh relaxation was comparable among groups in
mesenteric arteries, although SHR exhibited a greater NOS component to AChinduced relaxation than WKY. To gain mechanistic insight into sex and strain
differences in vascular function, NOS activity and NOS3 protein expression
were measured. Aortic NOS activity was comparable between groups and M
SHR had greater NOS3 expression than M WKY. In contrast, although vascular
function was largely maintained in mesenteric arteries of SHR, NOS activity
was less in SHR versus WKY. In conclusion, M SHR exhibit a decrease in NOS
regulation of vascular function compared to F SHR and WKY, although this is
not mediated by decreases in NOS activity and/or expression.

Introduction
Men have a greater incidence and severity of cardiovascular
disease compared to women until menopause (Gerhard and
Ganz 1995; Wiinberg et al. 1995). A similar sex disparity in
cardiovascular disease is seen in a number of experimental
animal models of hypertension, including spontaneously
hypertensive rats (SHR) (Kauser and Rubanyi 1995; Iliescu
et al. 2006). SHR are a genetic model of hypertension and,
similar to the human population, male SHR have a more
rapid increase in blood pressure over time compared to
female SHR. Although the molecular mechanisms responsi-

ble for sex differences in cardiovascular health and function
are still unclear, the nitric oxide (NO)/NO synthase (NOS)
pathway has been implicated in humans (Forte et al. 1998;
Sader and Celermajer 2002) and rats (Baylis et al. 1992;
Ribeiro et al. 1992; Kauser and Rubanyi 1994, Gamboa
et al. 2007) and we recently published that female SHR are
more dependent on NOS to maintain their blood pressure
than males (Brinson et al. 2013).
NO is a key molecule regulating endothelial and vascular function (Forte et al. 1998; Vaziri et al. 1998). In particular, loss of NOS-mediated control of vascular function
contributes to both the development and progression of
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cardiovascular disease (Anishchenko and Igosheva 1992;
McIntyre et al. 1997; Sader and Celermajer 2002; Orshal
and Khalil 2004). It is also well established that there are
sex differences in NO bioavailability, with females having
greater levels of NO than males (Forte et al. 1998;
Glushkovskaya-Semyachkina et al. 2006; Sullivan et al.
2010) and numerous studies have demonstrated that
greater NO in females contributes to maintaining cardiovascular function with age and disease relative to males
(McIntyre et al. 1997; Miller 2010; Baylis 2012). However,
whether there is differential NOS regulation of vasoconstriction and endothelial function in small and large arteries between males and females with normal blood
pressure or hypertension has not been fully determined.
The impact of NOS on vascular function may be dependent, in part, on the size and physiological role of the
artery. Decreases in NO bioavailability and NOSmediated vasorelaxation are commonly noted in conduit
arteries from male animal models of hypertension,
although we previously reported that NOS-mediated
vasorelaxation was maintained in small arteries from male
hypertensive rats (Sasser et al. 2004; Kang et al. 2007).
This finding is despite the fact that we and others have
previously shown that endothelial NOS (NOS3; eNOS)
protein expression is unchanged or even increased in the
vasculature in hypertensive male animal models including
SHR (Vaziri et al. 1998; Piech et al. 2003; Sun et al. 2013).
Therefore, the present study was designed to test the
hypothesis that SHR have impaired NOS-mediated regulation of vascular function (both constrictive and vasorelaxant) and reduced NOS activity and expression versus
Wistar-Kyoto rats (WKY). However, we further hypothesize that female SHR will maintain greater NOS-mediated
control of vascular function relative to males due to
greater levels of NO in female SHR. Studies employed
aorta, a conduit artery, and small mesenteric arteries and
the relative impact of NOS on both vasoconstriction and
vasodilation were measured in male and female SHR and
WKY.

Methods
Animals
Male and female SHR and WKY (Harlan Laboratories,
Indianapolis, IN) were studied. All experiments were conducted in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals, European Union Directive 2010/63/EU for animal
experiments and approved and monitored by the Georgia
Regents University IACUC. Rats were housed in temperature and humidity-controlled, light-cycled quarters and
maintained on a standard rodent diet (Teklad 8604,
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Madison, WI). At 12–13 weeks of age, rats were anesthetized with ketamine/xylazine (50 mg/kg and 6 mg/kg ip,
respectively; Phoenix Pharmaceuticals, St. Joseph, MO)
and thoracic aortas and third-order mesenteric arteries
were isolated.

Vascular reactivity
Thoracic aortas were cleaned of adherent adipose tissue,
cut into concentric rings, and mounted on pins for wire
myography (Danish Myo Technology A/S, Aarhus,
Denmark) as previously described (Sullivan et al. 2004; Loria et al. 2011). Similarly, third-order mesenteric arteries
were isolated, cleaned of adherent adipose tissue, cut into
segments, and mounted on wires for myography as previously described (Sullivan et al. 2004). Aortas preload tension was fixed to 28 mN, while mesenteric arteries preload
tension was 4 mN. Vessel segments were equilibrated for
30 min before the viability of the vessel was determined by
a robust vasoconstrictor response to 1 lmol/L phenylephrine (PE) followed by vasorelaxation to 10 lmol/L acetylcholine (ACh); only arteries that relaxed at least 80% of
the maximal PE-induced constriction were included in the
study. Drugs were rinsed out and the vessels were allowed
to reequilibrate for 30 min. Vasoconstriction was assessed
by performing cumulative concentration–response (CCR)
curves to the a-adrenergic agonist PE (1 9 10 9–
3 9 10 5 mol/L) in the absence or presence of the nonselective NOS inhibitor L-Nitro-Arginine Methyl Ester
(L-NAME, 15 min preincubation at 100 lmol/L, Sigma).
The ability of NO to attenuate PE-induced constriction, or
the vasoconstrictor buffering capacity of NOS (Loria et al.
2011), was calculated as the delta of area under the curve
(AUC, % increase in force 9 mol/L), determined by the
difference in PE-induced AUC  L-NAME. Vessel
segments were then rinsed, allowed to reequilibrate and
CCR curves were performed to KCl (8 9 10 3 to
100 9 10 3 mol/L) in the same artery segments. Vasoconstriction data are presented as percent increase in force
from baseline tension. Endothelial-dependent relaxation
was also assessed in aortic and small mesenteric artery segments following preconstriction with 1 lmol/L or 2 lmol/
L PE, respectively, followed by CCR curves to acetylcholine
(ACh; 1 9 10 9–1 9 10 5 mol/L) in the absence or
presence of the L-NAME (15 min preincubation at
100 lmol/L). Accordingly, delta AUC (% relaxation 9 mol/L) was determined by the difference in
ACh-induced AUC  L-NAME. There were no differences
in the level of precontraction between the different rat
groups. CCR curves were then performed to the endothelium-independent vasodilator sodium nitroprusside (SNP;
100 pmol/L to 31.6 lmol/L) in the same artery segments.
Vasorelaxation data are presented as percent relaxation
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from PE-induced constriction. For all CCR, maximum
response and sensitivity to the vasoactive agonists, pD2
(-logEC50), were calculated.
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Student’s t-test. For all comparisons, a value of P < 0.05
was considered statistically significant.

Results
NOS activity assay
Vascular tissue (whole aorta and mesenteric arterial beds)
were isolated from additional rats and homogenized as
previously described (Sullivan et al. 2010). Briefly, tissue
was snap-frozen and homogenized in cold homogenization buffer (20.0 mmol/L TrisHCl pH 7.4, 137.0 mmol/L
NaCl, 10% glycerol, and 1% NP40) containing protease
inhibitors (1 mmol/L PMSF, 1 lmol/L pepstatin A,
2 lmol/L leupeptin, and 0.1% aprotinin). To determine
total NOS enzymatic activity, tissue homogenates were
incubated with [3H]arginine (10 lmol/L final arginine,
71 Ci/mmol) in the presence of excess cofactors, as previously described, in a final volume of 50 lL for 30 min at
room temperature (Sullivan et al. 2010; Loria et al. 2011).
NOS activity was normalized to total protein concentration and expressed as pmoles citrulline/mg protein/
30 min. Protein concentrations were determined by standard Bradford assay (Bio-Rad, Hercules, CA) with the use
of BSA as the standard.

Western blot analysis
Western blotting was performed as previously described
using the same vessel homogenates that were used in the
NOS activity measurement (Sullivan et al. 2002, 2004).
Two-color immunoblots were analyzed using polyclonal
primary antibodies to NOS3 (1:500; BD Biosciences, San
Jose, CA) and b-actin (A1978, 1:10,000; Sigma, St Louis,
MO). After incubation with secondary antibody (IRDye
800-conjugated affinity-purified anti-mouse IgG, 1:2,000
or AlexaFluor 680-conjugated affinity-purified anti-rabbit
IgG, 1:2,000), the blot was scanned and the intensity of
specific bands were quantified using the Odyssey Infrared
Imaging System (LI-COR Biosciences, Lincoln, NE).
Densitometric results were reported normalized to bactin.

Data analysis
All values are expressed as mean  SEM. Percent increase
in force or relaxation in arteries, pD2 values, vasoconstrictor buffering capacity of NOS, and NOS activity in male
and female SHR and WKY were compared using a Twoway ANOVA with Bonferroni’s post hoc performed using
GraphPad Prism version 5.01 for Windows (GraphPad
Software, San Diego, CA). NOS3 protein expression maximal response and pD2 values in control and L-NAMEtreated vessels within each group were compared using a

Sex and strain differences in PE-induced
constriction and NOS capacity
Alpha-adrenergic-induced vasoconstriction was assessed
in isolated aorta and mesenteric arteries from male and
female SHR and WKY. PE-induced vasoconstriction was
not significantly different in aortic rings from male and
female WKY (Table 1 and Fig. 1A). However, PE-induced
vasoconstriction was greater in aortic rings from male
SHR compared with both female SHR and male and
female WKY. PE-induced constriction was comparable in
female SHR and WKY (effect of sex = P < 0.05; effect of
strain = NS; interaction = P < 0.05). Additional studies
assessed the ability of basal NO levels to attenuate
PE-induced constriction in the aorta. Preincubation with
L-NAME increased maximal constriction to PE in all
groups (Fig. 1B). The individual comparisons are
depicted in panel 1C. Vasoconstrictor buffering capacity
of NOS was significantly less in male SHR than in all
other groups (effect of sex = NS; effect of strain = NS;
interaction P < 0.05, Fig. 1D).
In contrast, maximal constriction to PE was comparable between all groups in small mesenteric arteries
(Fig. 2A). However, mesenteric arteries from SHR,
regardless of sex, had greater sensitivity to PE-induced
constriction than mesenteric arteries from WKY (Fig. 2A
and B; effect of sex = NS; effect of strain = P < 0.05;
interaction = NS). The individual comparisons are
depicted in panel 2C. Vasoconstrictor buffering capacity
of NOS in small mesenteric arteries was significantly
greater in SHR than in WKY (effect of sex = NS; effect of
strain = P < 0.05; interaction = NS, Fig. 2D).
Receptor-independent vascular contraction was also
assessed in response to increasing concentrations of KCl.
Maximal contraction was comparable in aortic rings from
all four groups (Table 1 and Fig. 3A), however, male rats
showed greater sensitivity to KCl-induced vasoconstriction than females regardless of strain. In addition, we
found strain differences in KCl-induced contraction in
small mesenteric arteries (Table 1 and Fig. 3B); small
mesenteric arteries from SHR displayed greater maximal
KCl-induced contraction and sensitivity compared to
WKY regardless of sex.

Relaxation
Endothelial-dependent vasorelaxation was assessed by performing CCR curves to ACh in aortic rings and small
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pD2, ( log EC50)
5.7  0.1
5.9  0.2
1.7  0.0
8.2  0.3
7.6  0.2
7.4  0.6

% Increase Force
303.2  43.5
314.9  43.5
132.8  7.3
% Relaxation
98.4  1.5
87.1  6.9
94.9  3.4

Mesenteric

pD2, ( log EC50)
9.93  0.17
10.25  0.13
1.82  0.12#
7.75  0.24
–
7.75  0.12

% Increase Force
95.1  4.7*
107.9  8.0#
97.2  4.2
% Relaxation
56.3  8.1 4/
–14.2  2.0
96.3  5.3

Aorta

pD2, ( log EC50)
4.1  0.2
2.7  0.1
1.3  0.7/
8.7  0.5
6.9  0.2w
7.7  0.6

% Increase Force
304.1  3.8
363.2  2.6
288.4  35.2*
% Relaxation
98.6  0.6
96.3  10.3
99.1  0.84

Mesenteric

Male SHR

pD2, ( log EC50)
9.98  0.10
10.41  0.08
2.15  0.12
7.09  0.21
–
7.52  0.16

% Increase Force
54.5  9.8
93.1  6.8
94.6  31.9
% Relaxation
82.1  2.2
–13.4  4.4
89.3  3.6

Aorta

pD2, ( log EC50)
5.6  0.1
6.1  0.1
1.7  0.8
7.8  0.2
7.7  0.2
7.8  0.6

% Increase Force
289.5  31.4
291.8  16.9
126.2  10.7
% Relaxation
95.5  1.7
79.9  11.6
92.4  1.1

Mesenteric

Female WKY

Methyl Ester; SHR, spontaneously hypertensive rats; WKY, Wistar Kyoto rats.
*P < 0.05 versus all other groups, #Significant versus female rats, /P < 0.05 versus WKY rats, wP < 0.05 versus non-treated rings.

pD2, ( log EC50)
10.39  0.17
10.54  0.07
1.74  0.09#
7.25  0.06
–
7.48  0.06

(B)
Treatment
PE
PE + L-NAME
KCl
ACh
ACh + L-NAME
SNP

L-NAME, L-Nitro-Arginine

% Increase Force
71.8  8.7
122.3  7.0#
98.8  1.0
% Relaxation
70.2  3.5
19.2  0.7*
93.0  2.6

(A)
Treatment
PE
PE + L-NAME
KCl
Treatment
ACh
ACh + L-NAME
SNP

Aorta

Male WKY

Table 1. Sensitivity and maximal responses to PE, ACh, SNP and KCl in absence or presence of a total nitric oxide synthase (NOS) inhibitor (L-NAME).

pD2, ( log EC50)
9.77  0.16
10.27  0.09
2.27  0.20
7.27  0.34
–
7.27  0.09

% Increase Force
49.3  9.2
96.1  4.5
99.2  2.5
% Relaxation
93.6  3.67
–14.7  4.7
90.4  1.4

Aorta

pD2, ( log EC50)
4.3  0.1
2.9  0.1
1.4  0.4/
8.9  0.3
7.1  0.1w
7.9  1.0

% Increase Force
331.5  44.2
354.1  24.3
289.4  22.5*
% Relaxation
100.1  1.3
90.5  2.9
96.4  1.7

Mesenteric

Females SHR
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Figure 1. Vasoconstriction induced by PE in aorta from male and female Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) in
the absence (A) or presence (B) of L-Nitro-Arginine Methyl Ester (L-NAME). Panel C illustrates the impact of L-NAME on PE-induced constriction
within each group. Panel D illustrates the ability of NO to attenuate PE-induced constriction, or the vasoconstrictor buffering capacity of nitric
oxide synthase (NOS), which was calculated as the change in the area under the curve in the presence or absence of L-NAME (% increase in
force 9 mol/L). *indicates significant difference in maximal % increase in force versus all other groups, P < 0.05. #indicates significant
differences in maximal % increase in force versus female rats, P < 0.05. windicates significant differences in maximal increase in force versus
nontreated control rings, P < 0.05; N = 5–7.

mesenteric arteries from male and female SHR and WKY.
Maximal relaxation to ACh was impaired in aorta from
male SHR compared with other groups (effect of sex =
P < 0.05; effect of strain = NS; interaction = P < 0.05,
Table 1, Fig. 4A). Sensitivity to ACh was comparable
between aortic rings isolated from male and female
SHR and WKY (Table 1B). L-NAME preincubation

dramatically blunted ACh-induced relaxation in male
WKY and female rats regardless of strain, however, male
WKY maintained a dilatory response to ACh in the presence of L-NAME (Fig. 4B). The individual comparisons
are depicted in panel 4C. Vasodilatory buffering capacity
of NOS in small mesenteric arteries was significantly
greater in female rats compared to male rats (effect of

ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.

2014 | Vol. 2 | Iss. 8 | e12125
Page 5

A. S. Loria et al.

Vascular Reactivity in Male and Female SHR and WKY

Small mesenteric arteries
400

M WKY

300

% Increase in force

M SHR
F WKY
F SHR

200
100
0

9

8.5

7

6.5

6

5.5

5

200
100

400

8.5

8

7.5

7

6.5

6

5.5

-log PE [mM/L]

5

300
200
100
8

7.5

7

6.5

6

-log PE [mM/L]

Delta area under the curve
PE±NAME

8.5

100

9

8.5

8

7.5

7

6.5

6

5.5

5

4.5

M SHR + L-NAME
M SHR

300
200
100
9

400

F WKY + L-NAME

9

200

0

4.5

F WKY

0

F SHR + L-NAME
F WKY + L-NAME

400

300

9

300

-log PE [mM/L]

M WKY

0

M SHR + L-NAME
M WKY + L-NAME

0

4.5

% Increase in force

% Increase in force

7.5

-log PE [mM/L]

M WKY + L-NAME

400

% Increase in force

8

% Increase in force

% Increase in force

400

5.5

5

8

7.5

7

6.5

6

-log PE [mM/L]

5.5

5

4.5

F SHR + L-NAME
F SHR

300
200
100
00

4.5

8.5

1

2

3

4

5

6

7

-log PE [mM/L]

8

9

10

900
600
300
0

M WKY

M SHR

F WKY

F SHR

Figure 2. Vasoconstriction induced by PE in small mesenteric arteries from male and female Wistar-Kyoto rats (WKY) and spontaneously
hypertensive rats (SHR) in the absence (A) or presence (B) of L-Nitro-Arginine Methyl Ester (L-NAME). Panel C illustrates the impact of L-NAME
on PE-induced constriction within each group. Panel D illustrates the ability of NO to attenuate PE-induced constriction, or the vasoconstrictor
buffering capacity of nitric oxide synthase (NOS), which was calculated as the change in the area under the curve in the presence or absence of
L-NAME (% increase in force 9 mol/L). / indicates significant differences in maximal % increase in force versus Wistar-Kyoto rats (WKY),
P < 0.05. windicates significant differences in maximal increase in force versus nontreated control rings, P < 0.05; N = 5–6.

sex = P < 0.05; effect of strain = P < 0.05; interaction = NS,
Fig. 4D).
Maximal relaxation to ACh in small mesenteric arteries
was similar in all groups (Table 1 and Fig. 5A). L-NAME
preincubation attenuated ACh-induced relaxation and
sensitivity in mesenteric arteries from SHR compared to
WKY (effect of sex = NS; effect of strain P < 0.05; interac-
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tion = NS, Fig. 5B). The individual comparisons are
depicted in panel 5C. Consequently, vasodilatory buffering
capacity of NOS in small mesenteric arteries was significantly greater in SHR compared to WKY (effect of sex = NS;
effect of strain = P < 0.05; interaction = NS, Fig. 5D).
To determine if sex and strain differences in response
to ACh were related to vascular smooth muscle sensitivity
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A
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#
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expression was similar in female SHR and WKY
(Fig. 6B).
In contrast, NOS activity was significantly greater in
small mesenteric arteries from WKY compared to SHR
(Fig. 7A); NOS activity was comparable between the sexes
in both strains. Consistent to what was observed in the
aorta, male SHR tended to have greater NOS3 expression
in small mesenteric arteries than male WKY and there
were no significant difference in NOS3 expression in
female SHR and WKY (Fig. 7B).

F SHR

0

0
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KCl, mM
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M WKY
M SHR

% Increase in force

Small mesenteric arteries

B

300

F WKY
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200
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8 12 16 20 25 32 40 50 63 79 100

KCl, mM
Figure 3. KCl-induced constriction in aortic (A) and small
mesenteric artery (B) rings from male and female Wistar-Kyoto rats
(WKY) and spontaneously hypertensive rats (SHR). #indicates
significant differences in maximal % increase in force versus female
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to NO, endothelial-independent vasorelaxation was also
assessed in response to SNP. SNP-induced relaxation was
similar in aortic and small mesenteric rings from male
and female SHR and WKY (Table 1).

Total NOS activity and expression in
vascular tissue
To begin to gain mechanistic insight into observed
changes in vascular function, NOS enzymatic activity and
NOS3 protein expression were assessed in aorta and mesenteric arteries of male and female SHR and WKY. Total
NOS enzymatic activity was comparable in aorta from
male and female SHR and WKY (Fig. 6A). Although
NOS activity was comparable, male SHR had greater
NOS3 protein expression than WKY; aortic NOS3 protein

Discussion
Loss of vascular NO results in impaired vasodilation and
enhanced vasoconstriction which have been suggested as a
common pathway in the pathogenesis of cardiovascular
disease (Giles et al. 2012). The current study examined
the impact of both sex and blood pressure status on
vascular function. At the age studied in the current manuscript, SHR have established hypertension and blood
pressure is higher in the males than in the females
(Sullivan et al. 2007; Tipton et al. 2014). In addition, we
studied both a large conduit vessel, the aorta, and a small
vessel to determine if the effects of sex and hypertension
are dependent on artery type. The central findings of the
current study are that male SHR exclusively exhibit
altered aortic function and decreases in the NOS contribution to vascular tone, while in mesenteric arteries SHR
of both sexes had enhanced vascular responses and
increases in the NOS-sensitive component. Based on the
central role played by small arteries in the regulation of
blood pressure, we hypothesize that SHR exhibit a compensatory increase in NOS in response to increases in
blood pressure to help maintain small artery function.
Additional studies are required to test this hypothesis
since neither sex nor strain altered NOS enzymatic activity, and NOS3 protein expression was not increased in
SHR compared to WKY. Regardless, there are sex and
strain differences in aortic versus mesenteric arterial
function and in the ability of NOS to modulate vascular
function.
PE-induced contraction and basal NOS-mediated attenuation of contraction were comparable in female SHR
and WKY, although impaired in male SHR relative to all
other groups. Basal NO availability in male and female
WKY and stroke-prone SHR (SHRSP) has also been
examined using L-NAME in PE-constricted aortic rings
(McIntyre et al. 1997). In contrast to our findings, basal
NO availability was reduced in aortas from SHRSP of
both sexes compared to WKY, although females of both
strains exhibited greater NO levels than males. Additional
studies reported that aortic rings from male and female
SHRSP exhibited greater PE-induced constriction than
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rings from WKY and confirmed decreases in basal NO in
both carotid arteries and aorta in SHRSP versus WKY
(Dowell et al. 1999; Kerr et al. 1999). The discrepancy in
these studies relative to ours may be related to
SHR/SHRSP strain differences. Indeed, consistent with
our study, aortic strips from male SHR exhibited greater
increases in active stress than strips from female SHR and
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this was accompanied by greater increases in calcium
influx (Crews and Khalil 1999a,b). Aortic segments from
male SHRSP also display greater contraction to calcium
and increased activation of STIM1 and Orai1 relative to
females, therefore, sex differences in calcium handling
and signaling in aorta from female SHR may contribute
to the maintenance of vascular function (Giachini et al.
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2012) relative to males. Alternatively, 12-week-old male
SHR have a higher blood pressure compared to females.
Therefore, while the mechanism responsible for the alterations in aortic function in male SHR is unknown, higher
blood pressure may also contribute.
Unlike aorta, small arteries play a physiologically key
role in the regulation of blood flow, and ultimately
contribute to blood pressure. Others have reported a
greater PE-induced contraction in small mesenteric arteries from SHR compared to WKY (Nyborg and Bevan

1988; Husken et al. 1994; Toot et al. 2011). In our study,
we found an increased sensitivity to PE only in SHR, with
similar maximal constriction in all groups. In addition,
despite decreased basal NO in aorta from male SHR, SHR
of both sexes exhibited an increase in NOS-mediated
attenuation of PE-induced contraction with no effect in
WKY, suggesting greater basal NO in small arteries from
hypertensive animals to attenuate PE-induced constriction. There were no sex differences in either strain in
PE-included constriction or the impact of L-NAME,
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A

B

Figure 6. Nitric oxide synthase (NOS) activity (A) and NOS3 protein
expression (B) in isolated aorta from male and female Wistar-Kyoto
rats (WKY) and spontaneously hypertensive rats (SHR). The first lane
in each representative Western blot indicates the molecular weight
marker. *indicates increased protein expression versus male WKY,
P < 0.05. N = 8–9.

consistent with our previous publications in SHR and
normotensive F344 Brown-Norway rats (Sullivan et al.
2004, 2009).
To further determine if sex/strain differences in
PE-induced contraction were due to differences in the
contractile machinery, we assessed KCl-induced contraction as well. KCl-induced maximal vasoconstriction in
aortic rings was similar in male and female WKY and
SHR; however, rings from male rats displayed greater KCl
sensitivity than from females regardless of strain. Our
data suggest that males have intrinsically increased contractile function compared to females. Consistent with
our data, it has been reported that in freshly isolated cells
from thoracic aorta that contraction triggered by calcium
as well the basal cytosolic calcium levels are reduced in
female rats regardless of the strain (Crews et al. 1999;
Murphy and Khalil 2000). These data further suggest,
however, that the sex/strain differences in PE-induced
constriction are not the result of innate differences in the
contractile machinery, but rather reflect differences in
a-adrenergic-induced contraction. In contrast, SHR of
both sexes exhibited greater maximal contraction to KCl
compared to WKY. While maximal contraction to PE was
not greater in SHR compared to WKY, there was an
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increased sensitivity, suggesting both alterations in calcium handling and overall contraction with the development of hypertension as well as sex and strain differences
in a-adrenergic-induced contraction.
Endothelial dysfunction is a key factor in the development of cardiovascular disease in men and women
(Ballerio et al. 2007; Skaug et al. 2013) and endotheliumdependent vascular relaxation to ACh is impaired in
patients with hypertension and in various experimental
models of hypertension (Ballerio et al. 2007; Gamboa
et al. 2007). Consistent with male SHR exhibiting
impaired aortic basal NO release, male SHR also exhibited an attenuation of ACh-induced relaxation in the
aorta. While only male SHR exhibited a decrease in maximal relaxation to ACh, aortic rings from males of both
strains exhibited less NOS-mediated relaxation compared
to females. In SHR, this was due to a decrease in overall
relaxation, while male WKY exhibited a degree of
NOS-independent relaxation not seen in the other groups.
This was an interesting finding since ACh-induced relaxation is almost exclusively dependent on NO (Furchgott
and Zawadzki 1980; Kauser and Rubanyi 1994). Future
studies will examine the mechanism responsible for the
residual relaxation to ACh in the presence of L-NAME in
male WKY, yet regardless, males of both strains exhibited
less agonist-stimulated NO release. While this is consistent with numerous reports that females have greater NO
levels than males (Kauser and Rubanyi 1994; Huang et al.
1998), it has previously been reported that aortic rings
from SHR of both sexes have impaired ACh relaxation
compared to WKY (Silva-Antonialli et al. 2000). However, in that study, SHR were older and males and
females were combined in a single group and not studied
separately. Therefore, the decrease in function could have
been “driven” by aortic segments from the males. In a
separate study, aortic rings from male and female SHRSP
exhibited greater sensitivity to ACh-induced relaxation
compared to WKY, although there were no apparent sex
differences (Dowell et al. 1999). It is tempting to speculate that impaired ACh-induced relaxation exclusively in
male SHR contributes to greater increases in blood
pressure or end-organ damage compared to females.
However, since the aorta is not an artery that regulates
blood pressure, additional studies also included small
mesenteric arteries.
Interestingly, ACh-induced relaxation was comparable
in all groups, although SHR exhibited greater NOS-mediated attenuation of the dilatory response compared to
WKY regardless of sex. L-NAME had minimal impact on
ACh-induced relaxation in WKY. In small mesenteric
arteries, ACh-induced dilation is mediated by NO, dilatory prostaglandins, and EDHF (Matrougui et al. 1997;
Takamura et al. 1999; Makino et al. 2000). Therefore, our

ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.

A. S. Loria et al.

Vascular Reactivity in Male and Female SHR and WKY

Small mesenteric arteries

NOS activity
(cpm/ mg protein/30 min)

A
200
150
100
50
0

B

W

S

W

S

W

M WKY

S

W

M SHR

F WKY

S

S W

F SHR

W

S

W

S

W

S

W

NOS 3
actin

0.6
0.4
0.2
0.0

WKY

SHR

NOS3 in females
Relative densitometric units

Relative densitometric units

NOS3 in males
0.8

1.0
0.8
0.6
0.4
0.2
0.0

WKY

SHR

Figure 7. Nitric oxide synthase (NOS) activity (A) and NOS3 protein expression (B) in the mesenteric arterial bed from male and female
Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). The first lane in each representative Western blot indicates the molecular
weight marker. /indicates significant difference from M WKY, P < 0.05. N = 8–9.

data suggest a shift in the balance of these dilatory pathways to maintain relaxation with hypertension, such that
the NOS-mediating component is increased, potentially in
response to increases in blood pressure to help limit
further increases in pressure and vascular dysfunction. In
contrast to our findings, relaxation to ACh in norepinephrine-precontracted mesenteric rings was attenuated
in both female and male SHR compared to WKY (Kauser
and Rubanyi 1995), however, the lack of a sex difference
in ACh-induced relaxation is consistent with previous
publications from our group (Sullivan et al. 2004, 2009).
Others have shown that the relative role of NO in the
endothelium-dependent and independent relaxation was
higher in female than in male SHR. However, the size of
the mesenteric arteries studied was not indicated in this
experiment therefore the results may be more relevant to
our findings in the aorta (Kahonen et al. 1998).
To gain insight into the molecular mechanisms by
which sex and strain impact vascular function, NOS activity and NOS3 expression were assessed. Despite both sex

and strain differences in the relative contribution of NOS
to impact vascular function, NOS enzymatic activity was
comparable among all groups. Moreover, NOS3 protein
expression was greater, not less, in aorta from male SHR
compared to male WKY and SHR did not have greater
NOS3 expression in the mesenteric arterial bed. Therefore, neither our measurements of NOS activity nor
NOS3 expression explained the sex and strain differences
in vascular function. It should be noted that NOS activity
was measured via an enzymatic assay in the presence of
excess amounts of all of the necessary cofactors and does
not necessarily reflect in vivo NOS activity or NO production. In a separate study, direct in vitro measurements
of NO in mesenteric arteries showed unchanged NO
release, but significantly greater NO decomposition by
reactive oxygen species (ROS) (Tschudi et al. 1996).
Indeed, the attenuated basal NOS component in aorta
from male SHR likely reflects differences in ROS production. NO bioavailability is determined not only by NOS
activity and expression but also by scavenging of NO by
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superoxide (Kerr et al. 1999) and male SHR have greater
levels of oxidative stress than female SHR (Yanes et al.
2005; Iliescu et al. 2006, 2007) and WKY (Kerr et al.
1999). Therefore, it is likely that greater levels of oxidative
stress in SHR compared to WKY, particularly in males,
contributes to the decrease in NOS buffering capacity in
aortic tissue. The potential even exists that maintained
NOS activity in SHR reflects uncoupled NOS activity, in
aortic rings from male and female SHRSP treatment with
L-NAME decreases in superoxide levels (Kerr et al. 1999),
directly implicating NOS as a source of ROS in the vasculature. It should also be noted that total NOS activity was
measured, not isoform-specific activity. In addition to
NOS3, NOS1 in particular is also found in the vasculature
and we have previously shown that NOS1 typically acts as
a break to increases in contraction (Sullivan et al. 2002)
in isolated mesenteric arteries. Therefore, there could be
isoform-specific changes in NOS activity, or NOS1
protein, which were not assessed in the current study.
It is tempting to speculate that in our study, the
reduced NOS buffering capacity to PE constriction may
contribute to differences in pulse pressure in a sex and
strain-dependent manner. Although not measured in the
current study, it has previously been shown that male
SHR show significantly higher pulse pressure than female
SHR while pulse pressure in the normotensive WKY rats
is comparable between males and females (ChamiotClerc et al. 2001; Maris et al. 2005). Furthermore, SHR
had greater pulse pressure than WKY rats when compared
for each gender. This may reflect sex and strain
differences in sympathetic nervous system activity, cardiac
contractility, stroke volume, vasomotor tone, and/or
vascular compliance.
In conclusion, we propose that SHR exhibit a functional increase in ACh-induced NO production in small
arteries to compensate for hypertension-induced vascular
damage. This study provides further evidence regarding
sex differences in the mechanism regulating vascular tone
in WKY and SHR.
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